EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS

/PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2022. Third Quarter Highlights and Outlook...

Related Keywords

Japan ,United States ,Michaela Mussallem ,Edwards Lifesciences ,Prnewswire Edwards Lifesciences ,Instagram ,Product Group ,Linkedin ,Twitter ,Drug Administration ,Exchange Commission ,Youtube ,Facebook ,Securities Exchange ,Edwards Lifesciences Corporation ,Program Discontinuation ,Quarter Highlights ,Aortic Valve Replacement ,Tricuspid Therapies ,Medical Devices Regulation ,Structural Heart ,Smart Recovery ,Hypotension Prediction Index ,Surgical Structural Heart ,Critical Care ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Report ,Consolidated Statements ,Generally Accepted Accounting Principles ,Property Litigation Expenses ,Fair Value ,Contingent Consideration Liabilities ,Intangible Assets ,Months Ended September ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Earnings ,Earnings Forecasts Amp Projections ,